Establishment Labs Holdings Inc. (ESTA)
Chart Events
Performance Outlook
| Previous Close | 48.00 |
| Open | 48.08 |
| Bid | 46.33 x 900 |
| Ask | 54.30 x 800 |
| Day's Range | 48.08 - 51.97 |
| 52 Week Range | 7.56 - 51.97 |
| Volume | 142,267 |
| Avg. Volume | 73,640 |
| Market Cap | 1.197B |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.68 |
| Earnings Date | Nov 09, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.33 |
- Business Wire
Establishment Labs Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in the 39th Annual J.P. Morgan Healthcare Conference, which is being held January 11-14, 2021. Mr. Chacón-Quirós is scheduled to speak to conference attendees at 4:30 pm ET on Thursday, January 14, 2021.
- Business Wire
Establishment Labs Reports Preliminary Results for Fourth Quarter and Fiscal Year 2020
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today reported preliminary revenue and cash figures for the fourth quarter and fiscal year ended December 31, 2020.
- Simply Wall St.
The Establishment Labs Holdings (NASDAQ:ESTA) Share Price Has Gained 31% And Shareholders Are Hoping For More
The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...
